Biotech Archives - Page 65 of 84 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

March 10, 2026

Parabilis Medicines Reports Early Clinical Data Showing Zolucatetide Reduces Polyp Burden in Familial Adenomatous Polyposis

March 5, 2026

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

MindImmune Secures $5 Million Investment from Alzheimer’s Drug Discovery Foundation to Advance Alzheimer’s Therapy

Innoviva Specialty Therapeutics Receives Strong Rating in 2026 Global Antimicrobial Resistance Benchmark

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

FDA Grants Priority Review to ENHERTU for High-Risk HER2-Positive Early Breast Cancer

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

Most Read

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

IFAW Urges Science-Based Conservation as Debate Over African Elephant Populations Intensifies

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

Parabilis Medicines Reports Early Clinical Data Showing Zolucatetide Reduces Polyp Burden in Familial Adenomatous Polyposis

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

POPULAR CATEGORY

ABOUT US

FOLLOW US